← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Camden's apartment portfolio stayed highly occupied and cash-generative while buybacks and debt rose sharply.
The read at a glance✓ Audited against SEC data
- Growth — Property revenue +1.9% to $1.57BNote
- Profitability — Net income +135.4% to $384.5MOK
- Cash quality — OCF +6.7% to $826.6MOK
- Balance sheet — Debt +11.9% to $3.90BWatch
- Capital — Dividends $460.9M; buybacks $270.7MWatch
- Insiders — 0 buys / 12 sellsWatch
- Accounting — REIT screens not shownNote
- Portfolio — 95% occupancy; $2,006 rentOK
Business
Camden Property Trust is a multifamily REIT that owns, manages, develops, repositions, redevelops, acquires, and constructs apartment communities. At December 31, 2025, it owned interests in, operated, or was developing 175 multifamily properties with 59,921 apartment homes.
Leadership changes
From CAMDEN PROPERTY TRUST's own filings, the day they're filed.
- Michael P. Gallagher · Chief Accounting Officer · departureeff. 2026-07-02
- Camden Property Trust · Chief Accounting Officer · departureeff. 2026-07-02
- Kevin J. Necas Jr · departureeff. 2026-07-02
Latest filings
- 8-K · Company announcement2026-08-31
- 8-K · Company announcement2026-08-03
- 10-Q · Quarterly report2026-07-31
- 8-K · Company announcement2026-07-30
- 8-K · Company announcement2026-06-11
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CAMDEN PROPERTY TRUST, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.